Callan Family Office LLC Buys Shares of 39,270 MetLife, Inc. (NYSE:MET)

Callan Family Office LLC bought a new position in shares of MetLife, Inc. (NYSE:MET) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 39,270 shares of the financial services provider’s stock, valued at approximately $3,215,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Bank of New York Mellon Corp lifted its position in MetLife by 109.2% during the 4th quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider’s stock worth $722,727,000 after acquiring an additional 4,606,748 shares during the period. Swedbank AB boosted its stake in shares of MetLife by 76.0% during the fourth quarter. Swedbank AB now owns 3,466,808 shares of the financial services provider’s stock valued at $283,862,000 after acquiring an additional 1,496,645 shares during the last quarter. Zurich Insurance Group Ltd FI purchased a new stake in shares of MetLife during the third quarter worth about $91,771,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its holdings in shares of MetLife by 79.1% during the third quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 1,726,209 shares of the financial services provider’s stock worth $142,378,000 after purchasing an additional 762,291 shares during the last quarter. Finally, Jacobs Levy Equity Management Inc. grew its holdings in MetLife by 256.6% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 948,223 shares of the financial services provider’s stock valued at $78,209,000 after buying an additional 682,333 shares during the period. 94.99% of the stock is owned by institutional investors and hedge funds.

MetLife Stock Performance

Shares of MET stock opened at $82.18 on Friday. The stock has a 50-day moving average of $83.72 and a 200-day moving average of $82.15. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.16 and a quick ratio of 0.16. The stock has a market cap of $55.98 billion, a PE ratio of 13.76, a price-to-earnings-growth ratio of 0.65 and a beta of 1.04. MetLife, Inc. has a one year low of $67.30 and a one year high of $89.05.

MetLife (NYSE:MET) last released its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. As a group, sell-side analysts expect that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be paid a $0.545 dividend. The ex-dividend date of this dividend is Tuesday, February 4th. This represents a $2.18 annualized dividend and a yield of 2.65%. MetLife’s dividend payout ratio (DPR) is presently 36.52%.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on MET. Wells Fargo & Company upped their price target on shares of MetLife from $92.00 to $97.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 19th. JPMorgan Chase & Co. upped their target price on shares of MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. StockNews.com cut shares of MetLife from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Keefe, Bruyette & Woods lowered their price objective on MetLife from $100.00 to $98.00 and set an “outperform” rating for the company in a research note on Wednesday, February 12th. Finally, BMO Capital Markets started coverage on MetLife in a research report on Thursday, January 23rd. They set a “market perform” rating and a $97.00 price objective for the company. Two analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to MarketBeat, MetLife presently has a consensus rating of “Moderate Buy” and an average price target of $94.58.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.